# Otrexup

NDC: 54436-017
Generic name: methotrexate
Labeler / Manufacturer: Antares Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20131011
Marketing ended: 20270430
FDA application: NDA204824

## Active ingredients

- METHOTREXATE: 17.5 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54436-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54436-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5